New Market Study, "Helicobacter Pylori Infections - Pipeline Review, H2 2013", Has Been Published
Global Markets Direct's, 'Helicobacter Pylori Infections - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Helicobacter Pylori Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Helicobacter Pylori Infections. Helicobacter Pylori Infections - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites,...
View full press release